CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
DM1-SMe is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
DMNB
25mg
| ≥98%
CSNpharm
DMNB
5mg
| ≥98%
CSNpharm
DMNQ
10mg
| ≥99%
CSNpharm
DMNQ increases ROS generation. It is a redox cycling agent that generates both superoxide and hydrogen peroxide intracellularly in a concentration dependent manner.
More Information
Supplier Page
DMNQ
1mg
| ≥99%
CSNpharm
DMNQ increases ROS generation. It is a redox cycling agent that generates both superoxide and hydrogen peroxide intracellularly in a concentration dependent manner.
More Information
Supplier Page
DMNQ
5mg
| ≥99%
CSNpharm
DMNQ increases ROS generation. It is a redox cycling agent that generates both superoxide and hydrogen peroxide intracellularly in a concentration dependent manner.
More Information
Supplier Page
DMOG
10mg
| ≥99%
CSNpharm
DMOG
250mg
| ≥99%
CSNpharm
DMOG
50mg
| ≥99%
CSNpharm
DMOG
100mg
| ≥99%
CSNpharm
DMT-dI
100mg
| ≥98%
CSNpharm
DMXAA
100mg
| ≥99%
CSNpharm
DMXAA is an apoptosis inducer with anti-vascular activity. It can inhibit STING and enzyme DT-diaphorase (Ki = 20 μM).
More Information
Supplier Page
DMXAA
5mg
| ≥99%
CSNpharm
DMXAA is an apoptosis inducer with anti-vascular activity. It can inhibit STING and enzyme DT-diaphorase (Ki = 20 μM).
More Information
Supplier Page
DMXAA
10mg
| ≥99%
CSNpharm
DMXAA is an apoptosis inducer with anti-vascular activity. It can inhibit STING and enzyme DT-diaphorase (Ki = 20 μM).
More Information
Supplier Page
DMXAA
50mg
| ≥99%
CSNpharm
DMXAA is an apoptosis inducer with anti-vascular activity. It can inhibit STING and enzyme DT-diaphorase (Ki = 20 μM).
More Information
Supplier Page
DNQX
25mg
| ≥99%
CSNpharm
DNQX
250mg
| ≥99%
CSNpharm
DNQX
100mg
| ≥99%
CSNpharm
DNQX
50mg
| ≥99%
CSNpharm
CSNpharm
Docosahexaenoic acid, an endogenous omega-3 fatty acid, acts as a selective retinoid X receptor (RXR) agonist that displays no activity at RAR, thyroid hormone receptor or the vitamin D receptor (VDR).
More Information
Supplier Page
CSNpharm
Docosahexaenoic acid, an endogenous omega-3 fatty acid, acts as a selective retinoid X receptor (RXR) agonist that displays no activity at RAR, thyroid hormone receptor or the vitamin D receptor (VDR).
More Information
Supplier Page
CSNpharm
Docosanoic Acid is a naturally occuring plant metabolite used to investigate the phase behavior of long-chain acids in supercritical propane.
More Information
Supplier Page
CSNpharm
Docosanoic Acid is a naturally occuring plant metabolite used to investigate the phase behavior of long-chain acids in supercritical propane.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Docosyl caffeate is a natural product isolated and purified from the roots of Glycyrrhiza uralensis Fisch exhibiting potent elastase inhibitory activity. Docosyl caffeate shows moderate antioxidant activity in DPPH and ABTS scavenging assays.
More Information
Supplier Page
CSNpharm
CSNpharm
Dofetilide is a potassium channel blocker that acts as a class III antiarrhythmic drug. It is used for the treatment of atrial fibrillation and flutter.
More Information
Supplier Page
CSNpharm
Dofetilide is a potassium channel blocker that acts as a class III antiarrhythmic drug. It is used for the treatment of atrial fibrillation and flutter.
More Information
Supplier Page
CSNpharm
Dofetilide is a potassium channel blocker that acts as a class III antiarrhythmic drug. It is used for the treatment of atrial fibrillation and flutter.
More Information
Supplier Page
CSNpharm
Dofetilide is a potassium channel blocker that acts as a class III antiarrhythmic drug. It is used for the treatment of atrial fibrillation and flutter.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Donepezil is a centrally acting reversible AchE inhibitor with IC50 of 8.12 nM and 11.6 nM for bAChE and hAChE, respectively, a medication used to treat Alzheimer’s disease.
More Information
Supplier Page
CSNpharm
Donepezil is a centrally acting reversible AchE inhibitor with IC50 of 8.12 nM and 11.6 nM for bAChE and hAChE, respectively, a medication used to treat Alzheimer’s disease.
More Information
Supplier Page
CSNpharm
Donepezil is a centrally acting reversible AchE inhibitor with IC50 of 8.12 nM and 11.6 nM for bAChE and hAChE, respectively, a medication used to treat Alzheimer’s disease.
More Information
Supplier Page